Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - CASH & EQUIVALENTS
Cash & Equivalents ITCI - Intra-Cellular Therapies, Inc.
148 M
LAST VALUE
26.48%
2 YEAR CAGR
21.88%
5 YEAR CAGR
15.44%
10 YEAR CAGR